Hilterapia® Course in Athens

01 December 2010 - Training -

The first advanced course on Hilterapia® in Greece will take place on December 4th and 5th in Athens at the Filoktitis Physiotherapy Clinic. There are going to be more than 70 participants, all users of the therapy.

The training course will be held by the teachers of ASAcampus Greece, George Vissarakis, Alexandros Sideris e George Kalorimis, and will be divided into two working days so to have two groups of less than 40 participants. In this way it will be possible to deepen all the topics giving the participants the possibility to play an active part.

 

You might also be interested in ...

See all articles

M-Hi laser training UK
News - 22/10/2025
From 30 September to 3 October, the tour visited three cities in the United Kingdom, involving physiotherapists and specialists who have chosen the M-Hi and HIRO TT laser systems.
Training ASAlaser devices for Taiwanese customers
News - 10/09/2025
The initiative offered a concrete and inspirational journey, allowing participants to delve deeper into the potential of the patented MLS® and Hilterapia® technologies, with a particular focus on the...
ASA Training Experience
News - 18/06/2025
Two immersive days of advanced clinical training as a privileged meeting point for health professionals interested in learning more about the use of Hilterapia® and MLS® Laser Therapy in therapeutic...
MLS Laser Therapy for TMD
Blog - 22/10/2025
A recent publication from Chulalongkorn University (Thailand) demonstrated how an integrated and conservative approach, supported by MLS® Laser Therapy, can offer highly effective clinical results.
M-Hi laser training UK
News - 22/10/2025
From 30 September to 3 October, the tour visited three cities in the United Kingdom, involving physiotherapists and specialists who have chosen the M-Hi and HIRO TT laser systems.
Press - 07/10/2025
Recent research and pilot studies highlight the benefits of laser therapy in treating radiodermatitis and peripheral neuropathy induced by radiation and chemotherapy for breast cancer.